A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above

NCT04510207 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
44101
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

China National Biotec Group Company Limited

Collaborators